Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    "congenital dyserythropoietic anemia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting The Congenital Dyserythropoietic Anemia Registry (CDAR)
Condition: Congenital Dyserythropoietic Anemia (CDA)
Intervention:
2 Unknown  GDF 15 in Sickle Cell Disease and Hereditary Spherocytosis
Conditions: Patients With Thalassemia Intermedia,;   Congenital Dyserythropoietic Anemia Type I
Intervention:
3 Unknown  Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC
Condition: CDA Type I
Intervention: Drug: omeprazole

Study has passed its completion date and status has not been verified in more than two years.